Health TrialsbyHealthPanel

Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

ConditionsIn Vitro Fertilization (IVF)Embryo Transfer
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age25-44
SponsorNational Taiwan University Hospital

About this trial

Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • GnRH agonist

    Drug

    GnRH agonist add to hcg for trigger

Treatment groups

170 Participants
are divided into 2 treatment groups
Group A: dualExperimental treatment 1 intervention
Group B: hcgNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Implantation

Implantation is defined as a positive serum β-hCG (\>20 mIU/mL) measured 14 days after embryo transfer.

Time frame
14 days after embryo transfer

Secondary outcomes

1

Clinical pregnancy

Clinical pregnancy is defined as visualization of a gestational sac on transvaginal ultrasonography one week after pregnancy has been confirmed.

Time frame
one week after confirm pregnancy
2

Ongoing pregnancy rate

An ongoing pregnancy is defined as a viable intrauterine pregnancy with fetal cardiac activity at ≥9 weeks' gestational age.

Time frame
5 weeks after confirmed pregnancy
3

Miscarriage rate

Time frame
before delivery
4

Gestational age (weeks) at delivery

Gestational age (weeks) at delivery

Time frame
delivery

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National Taiwan University Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: